Beautiful Virgin Islands

Thursday, Oct 30, 2025

Everything you need to know about Pfizer’s COVID-19 vaccine

Everything you need to know about Pfizer’s COVID-19 vaccine

Reported breakthrough in race to find coronavirus vaccine welcomed by scientists and leaders, but experts caution many questions remain.

Raising hopes for a major victory in the fight against the coronavirus pandemic, drugmakers Pfizer and BioNTech have said their experimental vaccine may be 90 percent effective at preventing COVID-19.

The announcement on Monday reverberated across the world, with stock markets surging to new records and political leaders welcoming the late-stage trial results – even as scientists and doctors cautioned many questions remained unanswered and warned any celebration would be premature.

As the efforts to contain a disease that has killed more than 1.25 million people and ravaged livelihoods globally, here is all you need to know about the promising vaccine.

What was announced?


The drugmakers’ trial involves some 44,000 people in six countries, half of whom have been administered with the vaccine, while the other half were given a placebo – a treatment designed to have no effect.

Monday’s data is from an interim analysis that was conducted after 94 participants in the continuing trial developed COVID-19. Fewer than nine of them who caught the disease had been given the vaccine.

To confirm the efficacy rate, Pfizer said it would continue its trial until there were 164 COVID-19 cases among volunteers, a number that the Food and Drug Administration (FDA) has agreed is enough to tell how well the vaccine is working.

The data, however, have yet to be peer-reviewed or published in a medical journal. Pfizer said it would do so once it has the results from the entire trial.

Outside experts said key details of the data need to be analysed and cautioned that many questions remain, including whether the vaccine can prevent severe disease or complications, how long it will protect against infection and how well it will work in the elderly.

How does this vaccine work?


When you get vaccinated, you are usually given either a weakened or a dead part of the virus, or the bacteria that causes an illness. In this way, the vaccine does not make you ill, but your body recognises that it is a foreign element and it mounts an immune response. This means that when your body comes across the real bug that causes that illness, it will be ready to attack it straight away.

The way this new vaccine works is called mRNA, meaning that you are not actually being injected with parts of the virus or a weakened form of it, but you are actually being administered with a part of the genetic code of the coronavirus. This tricks the body into producing some of the viral proteins itself so that the immune system then detects these proteins and starts to produce a defensive response to them.

What was the reaction?


Investors piled into banks stocks, airlines and other economically sensitive companies that had been battered by months of coronavirus-led lockdowns and travel bans, pushing major US stock indexes to fresh record highs.

Pfizer shares were indicated 6 percent higher in New York, while BioNTech’s US stock leapt 18 percent.

The World Health Organization said the results were very positive, but warned there was a funding gap of $4.5bn that could slow access to tests, medicines and vaccines in low- and middle-income countries.

Experts also warned there could be major challenges in distributing the vaccine, especially in poorer countries where power supplies are inadequate, as it must be stored at industrial deep-freeze temperatures to be effective.

What’s next?


Pfizer and BioNTech said they plan to apply to the FDA for emergency approval to use the vaccine by the end of the month, when they will have two months of safety data on about half of trial participants. This has raised the possibility of a regulatory decision as soon as December.

To save time, the companies began manufacturing the vaccine before they knew whether it would be effective. They now expect to produce up to 50 million doses, or enough to protect 25 million people, this year.

Pfizer said it expects to produce up to 1.3 billion doses of the vaccine in 2021.

Who is lining up to buy it?


Pfizer and BioNTech have a $1.95bn contract with the US government to deliver 100 million vaccine doses beginning this year. They have also reached supply agreements with the European Union, the United Kingdom, Canada and Japan.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×